Refractive Surgery News

Visus Therapeutics has started a clinical development program for an eye drop designed to restore loss of near vision due to presbyopia, according to a press release.

Two main classes of pharmaceutical therapies that use different mechanisms of action to treat presbyopia may be effective, noninvasive solutions for patients who are not yet good candidates for surgery.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

In our busy North Florida practice, more than one-third of our cataract patients choose femtosecond laser-assisted cataract surgery, a toric IOL and/or presbyopia correction.

Better preoperative, intraoperative and postoperative technologies, plus fears from the pandemic, may lead to increased interest in the premium lens market, according to a speaker at Octane’s virtual Ophthalmology Technology Summit.

More than 90% of eyes that underwent small incision lenticule extraction for high myopia correction experienced unchanged corrected distance visual acuity or gained one or more line at 36 months, according to a study.

The Schwind ATOS femtosecond laser has received CE approval, according to a press release from Schwind eye-tech-solutions.

In this video perspective from the virtual American Society of Cataract and Refractive Surgery meeting, P. Dee G. Stephenson, MD, discusses a study she presented on the enVista toric MX60ET hydrophobic acrylic IOL from Bausch + Lomb..

In this video perspective from the virtual Association for Research in Vision and Ophthalmology meeting, Jodhbir S. Mehta, MBBS, PhD, discusses a study on the implantation of the IC-8 IOL (AcuFocus) in patients with previous LASIK surgery.

European authorities granted STAAR Surgical approval to begin distributing the EVO+ Visian ICL with aspheric optic, according to a press release.